Project Grant F32AI186575
- This $492,000 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to conduct biochemical and structural characterization of the elongasome and divisome protein complexes in Mycobacterium tuberculosis (MTB) and the model organism Mycobacterium smegmatis. The research will use bacterial genetics and endogenous protein purifications to understand how these critical protein systems coordinate and interact to...
- This Project Grant award of $562,123.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to define the roles of small KH-domain RNA binding proteins in mycobacteria. The research, conducted by Worcester Polytechnic Institute, aims to determine the functional properties, target RNA binding, and impacts on RNA stability and cellular function of two mycobacterial RNA binding proteins,...
- This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
- This Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID, CFDA 93.855 Allergy and Infectious Diseases Research), provides $466,500.00 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to conduct research on the bacterial genetic basis underlying the transmissibility of tuberculosis (TB). The project aims to: (1) identify key mutations that drive high transmissibility in Mycobacterium tuberculosis (MTB) using a global collection of...
- This Project Grant award of $104,262, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to explore the relationship between genetic variants, transcriptional responses, and tuberculosis (TB) infection outcomes in macrophages derived from genetically diverse mice. The project aims to understand the basis for variability in TB infection outcomes, which may help identify ways to...
- This $194,940 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) with a start date of August 12, 2025 and an ultimate completion date of July 31, 2030. The primary goal of this research project is to discover the global human genetic regulators, including genes and genetic variants, that control macrophage antimicrobial responses to Mycobacterium tuberculosis (MTB) infection....
- This Project Grant award of $423,500 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to determine the potential of phenylalanine (Phe) biosynthesis as a novel drug target for treating tuberculosis caused by Mycobacterium tuberculosis (MTB). The award will enable the development of MTB strains that conditionally express enzymes in the Phe biosynthesis pathway, which will be used to...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $721,194 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Florida State University (FSU) to conduct research on membrane protein complexes involved in the cell division process of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB). The 5-year project, beginning March 1, 2025, aims to structurally characterize the FtsQ-FtsZ and FtsQ-FtsB-FtsL protein...
- This five-year, $813,838 project grant from the National Institute of Allergy and Infectious Diseases will fund research into the genetic and hormonal mechanisms underlying sex differences in tuberculosis (TB) and TB-HIV coinfection. The Johns Hopkins University will investigate how X chromosome complement and sex steroid hormones impact TB pathogenesis using cellular models, animal studies, and human samples. Researchers will utilize a novel four core genotype mouse model to differentiate the...
- This federal Project Grant award of $819,998.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), to The Regents of the University of California, San Francisco. The purpose of the award is to conduct research to understand how Mycobacterium tuberculosis (M. tuberculosis) infection triggers host cell death mechanisms, with the goal of identifying new therapeutic targets to augment protective...
MECHANISMS OF SIGMA-FACTOR-DEPENDENT TRANSCRIPTIONAL CONTROL IN MYCOBACTERIUM TUBERCULOSIS - PROJECT SUMMARY MYCOBACTERIUM TUBERCULOSIS (MTB) CAUSES 1.6 MILLION TUBERCULOSIS (TB) RELATED DEATHS PER YEAR, AND CURRENT TB THERAPEUTIC STRATEGIES ARE BECOMING INADEQUATE DUE TO THE EMERGENCE OF DRUG RESISTANT STRAINS. ONE OF THE PRIMARY ANTIBIOTICS USED TO TREAT TB INFECTION ACTS AT THE LEVEL OF TRANSCRIPTION, INHIBITING THE RNA POLYMERASE (RNAP). SIGMA FACTORS (S) ARE ACCESSORY SUBUNITS THAT ASSOCIATE WITH THE RNAP, DIRECTING A TRANSCRIPTION- COMPETENT RNAP HOLOENZYME TO UNIQUE GENES. THE SA RNAP HOLOENZYME IS RESPONSIBLE FOR TRANSCRIBING THE MAJORITY OF THE MTB GENOME, AND AS SUCH, REPRESENTS THE MAJOR RNAP-DEPENDENT DRUG TARGET. OF ALL THE SS FOUND IN MTB, ONLY SA CONTAINS A N-TERMINAL INTRINSICALLY DISORDERED REGION (IDR) WITH STRONG CHARGE SEGREGATION (I.E. CLUSTERING OF POSITIVELY/NEGATIVELY CHARGED RESIDUES). THE PROPENSITY FOR DISORDER AND CHARGE SEGREGATION IS CONSERVED NOT ONLY ACROSS MYCOBACTERIA, BUT MORE BROADLY ACROSS THE WHOLE ACTINOBACTERIA PHYLUM, SUGGESTING A FUNCTIONAL, YET UNCHARACTERIZED ROLE OF THESE SA IDRS IN BACTERIA. THIS PROPOSAL SEEKS TO UNDERSTAND THE ROLE OF THE MTB SA IDR IN TRANSCRIPTIONAL REGULATION, ASSESSING WHAT SEQUENCE AND CONFORMATIONAL FEATURES OF THE IDR ENCODE FUNCTIONALITY. LEVERAGING BOTH EXPERIMENTAL AND COMPUTATIONAL APPROACHES THAT OVERCOME THE TECHNICAL CHALLENGES ASSOCIATED WITH THE STRUCTURAL CHARACTERIZATION OF IDRS, I WILL ASSESS HOW THE CONFORMATIONAL DYNAMICS AND INTERACTIONS OF THE SA IDR IMPART TRANSCRIPTIONAL ACTIVITY. I WILL EMPLOY A COMBINATION OF IN VITRO KINETIC MEASUREMENTS FOR TRANSCRIPTIONAL ACTIVITY, SINGLE-MOLECULE FLUORESCENCE TECHNIQUES FOR MEASUREMENTS OF IDR CONFORMATIONS AND DYNAMICS, AND MOLECULAR DYNAMICS SIMULATIONS AND CROSS-LINKING MASS SPECTROMETRY FOR IDENTIFYING IDR- MEDIATED INTERACTIONS WITHIN THE RNAP HOLOENZYME. MEASUREMENTS WILL SPECIFICALLY INVESTIGATE THE ROLE OF CHARGE-SEGREGATED DISORDERED REGIONS AND POST-TRANSLATIONAL MODIFICATIONS AND BE PERFORMED UNDER CONDITIONS THAT MIMIC INTRACELLULAR IONIC CONCENTRATIONS DURING MTB INFECTION AND IN THE PRESENCE/ABSENCE OF ANTIBIOTICS. GIVEN THE BROAD CONSERVATION OF SEQUENCE FEATURES, CONCLUSIONS MADE WILL LIKELY BE APPLICABLE BEYOND MTB, LEADING TO A NEW PARADIGM FOR HOW BACTERIA USE IDRS IN TRANSCRIPTION. THE RESEARCH AND TRAINING OBJECTIVES IN THIS PROPOSAL WILL FURTHER THE UNDERSTANDING OF MECHANISMS OF GENE REGULATION UNIQUE TO DISEASE-CAUSING BACTERIA, WHILE ENABLING ME TO OBTAIN ADDITIONAL TECHNICAL TRAINING TO FOSTER THE FUTURE GENERATION OF ACADEMIC BIOMEDICAL INVESTIGATORS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $75.5k | 6/23/25 |